D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
INDV holding history
Indivior Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
INDV overviewAll 13F holders of INDVFull Q2 2026 holdings
- Shares (Q2 2026)
- 236,034
- Value
- $9.68M
- % of portfolio
- <0.1%
- Quarters held
- 7
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 236,034 | $9.68M | <0.1% | +32,049+15.7% | Added | Holders |
| Q1 2026 | 203,985 | $6.22M | <0.1% | +33,118+19.4% | Added | Holders |
| Q4 2025 | 170,867 | $6.13M | <0.1% | −42,387−19.9% | Reduced | Holders |
| Q3 2025 | 213,254 | $5.14M | <0.1% | +118,621+125.3% | Added | Holders |
| Q2 2025 | 94,633 | $1.39M | <0.1% | +26,529+39.0% | Added | Holders |
| Q1 2025 | 68,104 | $649.0K | <0.1% | −31,502−31.6% | Reduced | Holders |
| Q4 2024 | 99,606 | $1.24M | <0.1% | +99,606 | New | Holders |